CIK: 0001012622 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value ($000): $758,849 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | QUIDEL CORP | 1,795,462 | $393,889 | 51.9% | $24542.18 | — | COM | 74838J101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 2,074,800 | $134,883 | 17.8% | $49.53 | — | COM | G11196105 |
| — | AGENUS INC | 13,134,900 | $52,540 | 6.9% | $3.47 | — | COM NEW | 00847G705 |
| OPK | OPKO HEALTH INC | 13,355,773 | $49,283 | 6.5% | $3.45 | +22.2% | COM | 68375N103 |
| — | ACCELERATE DIAGNOSTICS INC | 4,091,749 | $43,618 | 5.7% | $22.26 | — | COM | 00430H102 |
| — | ASPIRA WOMENS HEALTH INC | 8,647,774 | $26,678 | 3.5% | $3.84 | — | COM | 04537Y109 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,721,459 | $16,991 | 2.2% | $4.92 | +17.0% | COM | 69404D108 |
| — | SOLENO THERAPEUTICS INC | 3,670,384 | $9,213 | 1.2% | $1.78 | — | COM NEW | 834203200 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 2,525,857 | $8,676 | 1.1% | $4.05 | +5.7% | COM | 09058V103 |
| — | QUIDEL CORP | 228,000 | $6,646 | 0.9% | $24542.18 | — | Call | 74838J101 |
| — | ANTARES PHARMA INC | 1,699,566 | $4,589 | 0.6% | $3.19 | — | COM | 036642106 |
| — | AMARIN CORP PLC | 1,015,501 | $4,275 | 0.6% | $494.19 | — | SPONS ADR NEW | 023111206 |
| — | MOTUS GI HLDGS INC | 3,806,666 | $3,721 | 0.5% | $3.08 | — | COM | 62014P108 |
| BIIB | BIOGEN INC | 3,688 | $1,046 | 0.1% | $213.68 | +30.5% | COM | 09062X103 |
| — | Y-MABS THERAPEUTICS INC | 25,212 | $968 | 0.1% | $26.10 | — | COM | 984241109 |
| — | CONTRAFECT CORP | 167,587 | $885 | 0.1% | $5.65 | — | COM NEW | 212326300 |
| — | BIOLASE INC | 1,739,100 | $478 | 0.1% | $1.21 | — | COM NEW | 090911207 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 68,100 | $423 | 0.1% | $49.53 | — | Call | G11196105 |
| — | AGENUS INC | 105,200 | $39 | 0.0% | $3.47 | — | Call | 00847G705 |
| — | AMARIN CORP PLC | 305,300 | $8 | 0.0% | $494.19 | — | Call | 023111206 |